Borderline Personality Disorder:
Historical and Future Perspectives
October 15-16, 2005
The Boston Burlington Marriott
Sponsored by: |
The National Education Alliance for Borderline Personality Disorder (NEABPD) and McLean Hospital |
Conference Objectives |
Global: The objectives of this program are to improve patient care and advance the understanding of professionals, families, and consumers about the complexities of the disorder. |
| Specific: At the conclusion of the conference, attendees will be able to better identify, specify, and describe:
|
|
Course Description |
Borderline Personality Disorder: Historical and Future Perspectives is specifically designed to offer those persons whose lives are impacted by the disorder – professionals, relatives, and consumers – a forum to better understand the complexities and issues of the disorder from various perspectives.
Internationally-recognized faculty will be joined by family members, consumers, and advocates to present up-to-date information pertaining to many aspects of the disorder. Day 1 will focus on topics such as criteria, diagnostic issues, inherent risks, medical issues, lifestyle issues, and medication, while Day 2 will offer information on the latest research findings and directions, family and consumer perspectives, and treatments. |
Conference Program
Welcome and Opening Remarks |
Christopher M. Palmer, M.D. Medical Director, Department of Postgraduate and Continuing Education, McLean Hospital Instructor in Psychiatry, Harvard Medical School |
| Perry D. Hoffman, Ph.D. President, National Education Alliance for Borderline Personality Disorder Assistant Clinical Professor, The Mount Sinai School of Medicine |
|
Criteria and Diagnosis |
John G. Gunderson, M.D. Director, Center for Treatment and Research on Borderline Personality Disorder, McLean Hospital Professor of Psychiatry, Harvard Medical School |
Managing Suicidality in BPD |
Joel Paris, M.D. Professor of Psychiatry, McGill University |
BPD: Medical Illness, Life-Style Choices, and Health Care Utilization |
Frances R. Frankenburg, M.D. Chief of Inpatient Psychiatry Edith Nourse Rogers Memorial Veterans Administration Medical Center, Bedford, MA Associate Professor of Psychiatry, Boston University School of Medicine |
Adolescents and BPD |
Alec L. Miller, Psy.D. Associate Professor of Psychiatry and Behavioral Sciences Chief, Child and Adolescent Psychology Director, Adolescent Depression and Suicide Program Montefiore Medical Center, Albert Einstein College of Medicine |
Trauma and the Development of Borderline Personality Disorder |
Bessel A. van der Kolk, M.D. Professor of Psychiatry, Boston University Medical School Medical Director, Trauma Center at HRI Hospital in Brookline, MA |
Family Research and A Family Program |
Perry D. Hoffman, Ph.D. President, National Education Alliance for Borderline Personality Disorder Assistant Clinical Professor, The Mount Sinai School of Medicine |
| Alan E. Fruzzetti, Ph.D. Associate Professor Director, Dialectical Behavior Therapy Program University of Nevada |
|
| Ellie Buteau, Ph.D. President, Social Research Solutions Part-time Faculty, Urban and Environmental Planning and Policy Department, Tufts University |
|
| Dixianne Penney, Dr.P.H. Executive Vice President, National Education Alliance for Borderline Personality Disorder Administrative Director, Center for the Study of Issues in Public Mental Health, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY |
|
Research in the Private Sector |
Sara A. Corya, M.D. Associate Medical Director, Eli Lilly and Company |
What Are We Medicating? |
S. Charles Schulz, M.D. Professor and Head, Department of Psychiatry University of Minnesota Medical School |
10-year Course of Borderline Personality Disorder |
Mary C. Zanarini, Ed.D. Director, Laboratory for the Study of Adult Development, McLean Hospital Associate Professor of Psychology in the Department of Psychiatry, Harvard Medical School |
Family and Consumer Perspectives |
Dixianne Penney, Dr.P.H. Executive Vice President, National Education Alliance for Borderline Personality Disorder Administrative Director, Center for the Study of Issues in Public Mental Health, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY |
| Kiera Van Gelder Artist and Director of MiddlePath Board Member, New England Personality Disorder Association |
|
| Debra Coates Executive Director, WiseMind |
|
| Hillary Eaton, M.A. Board Member, National Education Alliance for Borderline Personality Disorder Board Member, New England Personality Disorder Association |
|
| Kim Kay Hutchinson Co-President, National Alliance for the Mentally Ill, Greater Boston, Consumer Advocacy/Affiliate Network |
|
NIMH and Research Directions |
Wayne S. Fenton, M.D. Deputy Director for Clinical Affairs Division of Mental Disorders, Behavioral Research and AIDS Director, Division of Adult Translational Research and Treatment Development National Institute of Mental Health Bethesda, MD |
The History of What Led to Transference-Focused Psychotherapy (TFP) |
Otto F. Kernberg, M.D., F.A.P.A Professor of Psychiatry Weill Medical College of Cornell University Director, Personality Disorders Institute New York Presbyterian Hospital, White Plains, NY |
Dialectical Behavior Therapy: Recent Research and Developments |
Thomas R. Lynch, Ph.D. Assistant Professor Director, Duke Cognitive Behavioral Research and Treatment Program Department of Psychiatry and Behavioral Sciences Department of Psychology: Social and Health Sciences Duke University Medical Center and Duke University |
Systems Training for Emotional Predictability and Problem Solving (STEPPS’) Approach to Treatment of BPD |
Nancee Blum, M.S.W., L.I.S.W. Social Work Specialist and Clinical Faculty, Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa Adjunct Faculty, College of Medicine, College of Nursing, and School of Social Work |
How to Help Borderline Patients Recognize Feelings in Themselves and Others |
Anthony W. Bateman, M.D., FRCPsych Consultant Psychiatrist and Psychotherapist St. Annés Hospital, London Visiting Professor, University College, London |
Interactive Treatment Panel |
Moderator: John G. Gunderson, M.D. Director, Center for Treatment and Research on Borderline Personality Disorder, McLean Hospital Professor of Psychiatry, Harvard Medical School |
Closing Remarks |
Patricia Woodward, M.A.T. Secretary, National Education Alliance for Borderline Personality Disorder Board Member, New England Personality Disorder Association |